Celgene received a positive opinion for its pancreatic-cancer treatment Abraxane from a European committee, paving the way for potential approval of the treatment there.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304337404579213672925489090.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304337404579213672925489090.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento